Corona Virus Health medical

Gilead injectable drug to treat hospitalised Covid-19 patients

Hyderabad-based Hetero will launch remdesivir, an injectable drug from Gilead, to treat hospitalised Covid-19 patients within this week. The company will first make the drug available in the main disease burden areas of Maharashtra and Delhi under the brand Covifor.   A single dose vial is likely to cost between Rs 5,000-6000, the company said. Read More…